Verdant Bioscience develops oil palm F1 hybrid varieties and other supporting technologies that underpin significant yield increases and productivity enhancements.
Included in the AvH investment portfolio since 2020.
42 %
Beneficial interest AvH
Key figures
$ 4.6 m
Turnover (2025)
$ -4.2 m
Net result (2025)
436
Employees (2025)